HEALTH● LOW1h ago · Sep 25, 2026, 11:00 AM
NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.
CNBC · north america
A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoResearchers document first human deaths by Caspian cobra in IndiaThe HinduHEALTH2h agoGaneshotsav: Maharashtra FDA seizes 6.34 lakh kg of suspected adulterated foodThe HinduHEALTH2h agoMozambique faces rising drug use as trafficking routes fuel local addictionAfricanews [en]HEALTH3h agoPrime Medicine stock jumps 8% after FDA clears PM647 trialSeeking Alpha Tech